ATE190630T1 - Angiotensin-ii typ-1 rezeptor und dessen herstellung - Google Patents
Angiotensin-ii typ-1 rezeptor und dessen herstellungInfo
- Publication number
- ATE190630T1 ATE190630T1 AT93105758T AT93105758T ATE190630T1 AT E190630 T1 ATE190630 T1 AT E190630T1 AT 93105758 T AT93105758 T AT 93105758T AT 93105758 T AT93105758 T AT 93105758T AT E190630 T1 ATE190630 T1 AT E190630T1
- Authority
- AT
- Austria
- Prior art keywords
- angiotensin
- production
- type
- protein
- receptor
- Prior art date
Links
- 102000010913 Type 1 Angiotensin Receptor Human genes 0.000 title 1
- 108010062481 Type 1 Angiotensin Receptor Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108020004414 DNA Proteins 0.000 abstract 1
- 101000690425 Homo sapiens Type-1 angiotensin II receptor Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000013513 substance screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8544592 | 1992-04-07 | ||
| JP10139392 | 1992-04-21 | ||
| JP2783593 | 1993-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE190630T1 true ATE190630T1 (de) | 2000-04-15 |
Family
ID=27285967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93105758T ATE190630T1 (de) | 1992-04-07 | 1993-04-07 | Angiotensin-ii typ-1 rezeptor und dessen herstellung |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5427922A (de) |
| EP (1) | EP0585520B1 (de) |
| AT (1) | ATE190630T1 (de) |
| CA (1) | CA2093495A1 (de) |
| DE (1) | DE69328060T2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5427922A (en) * | 1992-04-07 | 1995-06-27 | Takeda Chemical Industries, Ltd. | DNA encoding a new angiotensin II type 1 receptor subtype and its expression |
| US5688640A (en) * | 1994-08-10 | 1997-11-18 | Board Of Regents, The University Of Texas System | Methods of screening of effectors of endothelin converting enzyme-1 |
| US5736376A (en) * | 1995-12-19 | 1998-04-07 | Board Of Regents, The University Of Texas System | Recombinant endothelin converting enzyme-2 and its use in ECE inhibitor screening |
| US6306826B1 (en) | 1997-06-04 | 2001-10-23 | The Regents Of The University Of California | Treatment of heart failure with growth hormone |
| CA2314811A1 (en) * | 2000-08-02 | 2002-02-02 | Brian Archibald Macvicar | Autoimmunity to angiotensin at1 receptors in schizophrenia |
| EP1343006A4 (de) * | 2000-11-15 | 2007-06-06 | Akiko Itai | Verfahren zur charakterisierung von proteinen |
| US7250265B2 (en) | 2001-04-06 | 2007-07-31 | Marshfield Clinic | Method of detecting and evaluating angiotensinogen receptor-modulating compounds using placental cells |
| GB0219524D0 (en) | 2002-08-21 | 2002-10-02 | Queen Mary & Westfield College | Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| WO2004099772A2 (en) * | 2003-05-06 | 2004-11-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr1a (agtr1a) |
| GB0802931D0 (en) | 2008-02-18 | 2008-03-26 | Queen Mary & Westfield College | Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5427922A (en) * | 1992-04-07 | 1995-06-27 | Takeda Chemical Industries, Ltd. | DNA encoding a new angiotensin II type 1 receptor subtype and its expression |
-
1993
- 1993-03-31 US US08/041,219 patent/US5427922A/en not_active Expired - Fee Related
- 1993-04-06 CA CA002093495A patent/CA2093495A1/en not_active Abandoned
- 1993-04-07 EP EP93105758A patent/EP0585520B1/de not_active Expired - Lifetime
- 1993-04-07 DE DE69328060T patent/DE69328060T2/de not_active Expired - Fee Related
- 1993-04-07 AT AT93105758T patent/ATE190630T1/de not_active IP Right Cessation
-
1995
- 1995-04-05 US US08/417,122 patent/US5595882A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5427922A (en) | 1995-06-27 |
| DE69328060T2 (de) | 2000-07-13 |
| EP0585520B1 (de) | 2000-03-15 |
| DE69328060D1 (de) | 2000-04-20 |
| US5595882A (en) | 1997-01-21 |
| EP0585520A1 (de) | 1994-03-09 |
| CA2093495A1 (en) | 1993-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE162532T1 (de) | Merschliches cnp-gen und vorläufer protein | |
| IL127115A0 (en) | Novel protein and method for preparing it | |
| ATE125867T1 (de) | Fibronektinbindungsprotein und dessen herstellung. | |
| DE69435038D1 (de) | Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie | |
| DK0672138T3 (da) | Kimære prokoagulante proteiner | |
| ATE189475T1 (de) | Wachstums-differenzierungsfaktor der tgf-b familie | |
| NO20090583L (no) | Terapi for alfa-galaktosidase A-mangel | |
| ATE244304T1 (de) | Verfahren zur veränderung des essverhaltens, dafür verwendbare verbindungen und dna, die einen hypothalamischen atypischen neuropeptid y/peptid yy rezeptor (y5) kodiert | |
| BR9710435A (pt) | Genes de moraxella receptores de transferrina | |
| ES2063278T3 (es) | Proteina morfogenetica de hueso. | |
| DK672788A (da) | Rekombinant-dna-vektorer til direkte udtrykkelse af aktiveret humant protein c | |
| ATE348632T1 (de) | Prion protein peptide und deren verwendung | |
| FI885504A0 (fi) | Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning. | |
| ATE190630T1 (de) | Angiotensin-ii typ-1 rezeptor und dessen herstellung | |
| PT817851E (pt) | Dna codificador do virus do papiloma humano tipo 18 | |
| ATE120494T1 (de) | Fibronectinbindungsprotein und dessen herstellung. | |
| EP0990703A4 (de) | Neues polypeptid, dafür kodierende dna und deren verwendungen | |
| ATE142256T1 (de) | Polypeptid und dessen herstellung | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| UA72875C2 (uk) | БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ | |
| DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| EP0723016A3 (de) | Leukocyten-aktivierender Faktor | |
| ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. | |
| FI921356A0 (fi) | Somatostatinreceptor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |